MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » FDA clears SurGenTec synthetic bone graft

FDA clears SurGenTec synthetic bone graft

By

SurGenTec announced today that it received FDA 510(k) clearance for its proprietary OsteoFlo NanoPutty quadphasic synthetic bone graft.

Boca Raton, Fla.-based SurGenTec said in a news release that its novel OsteoFlo NanoPutty bone graft features the world’s first and only quadphasic synthetic bone graft particles with nano-surface technology for providing an “optimal resorption profile with unrivaled handling characteristics.”

OsteoFlo requires no mixing, reconstituting or preparation prior to use and is designed to maximize flowable properties when used in minimally invasive surgery. The putty does not harden and can flow through tiny apertures and voids.

The putty comes in two packaging configurations, either a standard syringe or a pre-filled, minimally invasive cartridge that can be used with SurGenTec’s GraftGun single-use bone graft delivery system.

SurGenTec is eyeing a launch for the OsteoFlo NanoPutty in October 2020, and also plans to garner CE Mark approval to market it overseas.

“We are thrilled to announce the addition of OsteoFlo NanoPutty to our portfolio. Our team has put years into research and development to create this truly unique synthetic bone graft putty,” SurGenTec founder & CEO Travis Greenhalgh said in the release. “Our team managed to put four biocompatible materials with different resorption profiles into one particle with nano-surface technology. These particles are also suspended in a unique combination of bioresorbable polymers that give the product superior handling characteristics.”

In case you missed it

RSS From Medical Design & Outsourcing

  • 3M slightly down despite Street-beating Q3
    3M (NYSE:MMM) shares took a slight dip today on third-quarter results that finished ahead of the consensus forecast. The St. Paul, Minn.-based company posted profits of $1.4 billion, or $2.43 per share, on sales of $8.4 billion for the three months ended Sept. 30, 2020, for a -10.7% bottom-line slide on sales growth of 4.5%. Adjusted… […]
  • Dynocardia lands spot in Dassault Systèmes startup accelerator
    Medtech startup Dynocardia, which is developing a continuous, non-invasive blood pressure (BP) measuring device, announced today that it has been selected for the Dassault Systèmes 3DExperience Lab accelerator program. Participation in the accelerator could help Dynocardia expedite the development of its ViTrack technology, which the company touts as a solution to problems stemming from inaccurate,… […]
  • The 11 largest medtech employers of 2020 – and what their employees really think
    Employees of the 11 largest medtech employers are proud of working on life-saving products with added benefits due to the COVID-19 pandemic, but also reported frustration with big corporate bureaucracy. That was one major takeaway as Medical Design & Outsourcing compiled some current and former employee reviews posted on Glassdoor. The companies are the largest… […]
  • Integer gets $28M from long-running patent spat
    Integer Holdings (NYSE:ITGR) said today it has received a payment of approximately $28 million resulting from its July 2020 patent victory against AVX. An appeals court upheld a $22.2 million jury verdict in July in the long-standing patent spat between Integer, formerly known as Greatbatch, and AVX, now part of Kyocera. Integer said it has applied… […]
  • Cleveland Clinic study finds no advantage to robotic hernia surgery
    A small study out of the Cleveland Clinic has found no apparent clinical benefit to the use of surgical robotics in abdominal hernia repairs using intraperitoneal mesh. Laparoscopic intraperitoneal mesh placement is notoriously painful in the early postoperative period, and rates of chronic pain, bulging, with patient dissatisfaction as high as 25%, the researchers noted.… […]
  • Tegra Medical expands into Europe, Asia
    Contract manufacturer Tegra Medical today announced it is expanding operations into Europe and Asia. The expansion will give Tegra a presence in nine locations on three continents: Altstätten, Hallau, and Heerbrugg, Switzerland; Johor Bahru, Malaysia; and Nantong, China. The Asia central office is located in Singapore. “With its unparalleled expertise in making some of the industry’s… […]
  • FDA clears Life Spine revision device
    Life Spine announced today that it has received FDA clearance to market a sacroiliac (SI) revision offering and additional claims for the SImpact sacroiliac joint fixation system. The new clearance adds a 14.5mm diameter screw to Life Spine’s SI fixation portfolio to fill a gap in the market for revision surgeries. The larger screw joins… […]
  • MEDX Xelerator expands startup portfolio
    Israel-based medical device and digital health incubator MEDX Xelerator today announced it has added three new companies to its portfolio: Dimoveo Medical, a developer of ultrasound-based infection treatment and prevention. Swift Duct, a company working to reduce the incidence of post-endoscopic retrograde cholangial-pancreatography (ERCP) pancreatitis. Synchrony Medical, a creator of a respiratory therapy device to… […]
  • DTW Podcast: Under Landon, Philips bent on growing minimally invasive tools
    In this week’s DeviceTalks Weekly podcast, we visit with Chris Landon, SVP and business leader of image-guided therapy devices at Philips, about that company’s plans to build a medtech powerhouse. Here’s a partial, edited transcript. Why did you enter medtech? Bill George, the former CEO of Medtronic, mentored me while I was doing my MBA… […]
  • Is this the next generation of orthopedic device outsourcing?
    Major orthopedic device companies appear to be shifting the entire manufacturing and sourcing of certain products to their suppliers. Orchid Orthopedic Solutions is positioning itself to be in the vanguard of orthopedic device outsourcing.  Orchid Orthopedic Solutions (Holt, Mich.) and its Orchid Supply+ offering could be a great example of how outsourcing in the orthopedic… […]
  • Could this hydrogel repair damaged nerves?
    Researchers in China are touting a hydrogel that could be used to repair certain damaged nerves one day. Qun-Dong Shen, Chang-Chun Wang, Ze-Zhang Zhu and colleagues are developing a stretchable, conductive hydrogel in an effort to find a method for repairing peripheral nerves that, when damaged, result in chronic pain, neurologic disorders, paralysis or disability.… […]